activating

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Spool launches its Smart Vault tool to radically simplify risk-managed yield portfolio creation

Source Node:
Time Stamp: September 21, 2022 3:38 PM - Modified On: September 21, 2022 - Published By:
Source Cluster:
Republished By Plato

Created to alleviate DeFi investment obstacles, Spool’s flagship service empowers individuals and institutions to easily build diversified, risk-adjusted yield portfolios that are auto-compounding and auto-rebalanced. September 2022— Spool, the DAO creating a platform to build seamless DeFi products for investors of all backgrounds, launches its Smart Vault creation tool. Smart Vaults enable individuals and institutions to create customizable and diversified yield portfolios. Through a 5-step Smart Vault, or “Spool,” creation process, users can tailor all aspects of their portfolio, including assets, risk models, strategies, and allocations, to their goals. Digital